Making avian influenza vaccines available, an industry point of view (IFAH)

Developments in Biologicals

Volumn 124, Issue , 2006, Pages 151-155

  Van Aarle, P ^a  

^a INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ANIMAL; AVIAN INFLUENZA; CONFERENCE PAPER; GENETICS; HEALTH SURVEY; INFLUENZA VIRUS A; METHODOLOGY; MOLECULAR EVOLUTION; POULTRY;

ANIMALS; EVOLUTION, MOLECULAR; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POPULATION SURVEILLANCE; POULTRY;

EID: 33644618085     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (11)

1. Stegeman A, Bouma A, Eibers AR, de Jong MC, Nodelijk G, de Klerk F, Koch G, van Boven M: Avian influenza A virus (H7N7) epidemic in The Netherlands in 2003: Course of the epidemic and effectiveness of control measures. J Infect Dis 2004; 190: 2088-2095.
2. st General Session of the International Committee of the World Organisation for Animal Health, Paris, 18-23 May 2003. http://www.oie.int/downld/71SG_2003/A_71% 20SG_12_CS3E.pdf.
3. EU Commission Decision of 29 September 2004 on introducing vaccination to supplement the measures to control infections with low pathogenic avian influenza in Italy and on specific movement control measures and repealing Decision 2002/975/EC. EU Commission Decision 2004/666/EC.
4. Swayne DE, Beck JR, Perdue ML, Beard CW: Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 Avian Influenza. Avian Dis 2001; 45: 355-365.
5. Ellis TM, Leung CYHC, Chow MKW, Bissett LA, Wong W, Guan Y, Peiris MJS: Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Path 2004; 33 (4): 405-412.
6. Swayne DE, Garcia M, Beck JR, Kinney N, Suarez DL: Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 2000; 18: 1088-1095.
7. Capua I, Terregino C, Cattoli G, Mutinelli F, Rodriguez JF: Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Path 2002; 32: 47-55.
8. Tumpey TM, Alvarez R, Swayne DE, Suarez DL: Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the non-structural protein of influenza A virus. J of Clin Microbiol 43 (2): 676-683.
9. Swayne DE, Beck JR, Garcia M, Stone HD: Influence of virus strain and antigenic mass on efficacy of H5 influenza inactivated vaccines. Avian Path 1999; 28: 245-255.
10. Lee CW, Senne D, Suarez DL: Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 2004; 78 (15): 8372-8381.
11. Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products. EU Commission Directive 2001/82/EC.